Patent Assignment
Reel/Frame 035778/0686
Merger
Recorded: 2015-06-03
Pages: 4
Assignor
MEDAREX, L.L.C.
Executed: 2014-09-30
Assignee
E. R. SQUIBB & SONS, L.L.C.
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NEW JERSEY, 08540
Covered Properties
(3)
Matriptase Protein and Uses Thereof
Fully Human Antibodies Specific to CADM1
Fully Human Antibodies Specific to CADM1
Application:
13/728,059 →
Publication:
US 2013/0156788
Related Assignments
(11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 1, 2010
From: TERRETT, JONATHAN ALEXANDER
To: MEDAREX, INC.
Reel/Frame 024622/0290 →
Assignment of Assignor's Interest
Jul 12, 2010
From: ROHLFF, CHRISTIAN
To: OXFORD BIOTHERAPEUTICS LIMITED
Reel/Frame 024666/0097 →
Assignment of Assignor's Interest
Nov 7, 2011
From: TERRETT, JONATHAN ALEXANDER; LEBLANC, HEIDI N.; HUANG, HAICHUN; MEADDOUGH, ERIKA
To: MEDAREX, INC.
Reel/Frame 027186/0107 →
Assignment of Assignor's Interest
Jan 14, 2013
From: MEDAREX, INC.
To: OXFORD BIOTHERAPEUTICS LTD
Reel/Frame 029623/0007 →
Assignment of Assignor's Interest
Jan 14, 2013
From: TERRETT, JONATHAN ALEXANDER; LEBLANC, HEIDI N.; HUANG, HAICHUN; MEADDOUGH, ERIKA
To: MEDAREX, INC.
Reel/Frame 029623/0031 →
Merger
Jun 13, 2013
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 030603/0924 →
Merger
May 8, 2014
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 032848/0038 →
Merger
May 8, 2014
From: MEDAREX, INC.
To: MEDAREX, L.L.C.
Reel/Frame 032847/0831 →
Security Interest
Aug 28, 2019
From: OXFORD BIOTHERAPEUTICS INC.; OXFORD BIOTHERAPEUTICS LTD.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 050197/0172 →
Release of Security Interest
Jan 26, 2021
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: OXFORD BIOTHERAPEUTICS INC.; OXFORD BIOTHERAPEUTICS LTD.
Reel/Frame 055027/0606 →
Release of Security Interest
Jan 26, 2021
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: OXFORD BIOTHERAPEUTICS INC.
Reel/Frame 055026/0720 →